Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life
Year: 2021
Type: article
Study design: Case Report
Source: Chemotherapy
DOI: 10.1159/000513989
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3133845320
